BWXT Reports Third Quarter 2018 Results

BWXT news button on keyboard

Highlights • 3Q18 revenue growth of 1.5%; 3Q18 orders up significantly; backlog at $3.8 billion • 3Q18 GAAP EPS of $0.78 and non-GAAP EPS of $0.40, each inclusive of a $0.21 negative impact for missile tube reserves • Returned $79 million to shareholders in 3Q18; approved a new $250 million share repurchase authorization • Updated […]

BWXT Reports Solid Second Quarter 2018 Results with Strong Revenue Growth

BWXT news button on keyboard

Highlights • 2Q18 strong revenue growth of 7%; 2Q18 orders up significantly • 2Q18 GAAP EPS of $0.60; 2Q18 non-GAAP EPS of $0.58 • Reiterated 2018 non-GAAP EPS guidance of $2.45 to $2.55 despite higher interest expense and integration costs • Completed acquisition of Nordion medical isotope business on July 30, 2018 View the full […]

BWX Technologies Reports Robust First Quarter 2018 Results with Strong Revenue Growth

Highlights: • 1Q18 GAAP EPS of $0.66, up 20%; 1Q18 non-GAAP EPS of $0.67, up 22%• Strong revenue growth of 7% with expanding segment margins• Consolidated backlog remains healthy at $3.6 billion• Reiterated 2018 guidance: EPS of $2.45 to 2.55; revenue of $1.75 to 1.85 billion View the full release on our Investors Relations page. […]

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.